Literature DB >> 10462166

Anxiety of Alzheimer's disease: prevalence, and comorbidity.

L Teri1, L E Ferretti, L E Gibbons, R G Logsdon, S M McCurry, W A Kukull, W C McCormick, J D Bowen, E B Larson.   

Abstract

BACKGROUND: Anxiety may be associated with psychiatric morbidity, disability, increased health care utilization, and mortality in Alzheimer's disease (AD) patients as it is in the general adult population. However, the phenomenology of anxiety symptoms in AD and its relationship to dementia progression, comorbid depression, and the presence of other problematic behaviors have not yet been examined.
METHOD: Data on anxiety symptoms and their coexistence with other factors were obtained in 523 community-dwelling AD patients through interviews with their caregivers and direct physical examination. The prevalence of anxiety symptoms and their association to patient depression, other behavioral problems, gender, and age was investigated.
RESULTS: Anxiety symptoms were common, occurring in 70% of subjects. Anxiety symptoms were significantly correlated with ADL impairment and other behavioral disturbances, including wandering, sexual misconduct, hallucinations, verbal threats, and physical abuse. Comorbidity of anxiety-depression was also prevalent: 54% of the sample had both anxiety and depression symptoms. ADL impairment and problem behaviors were significantly associated with comorbidity; however, the latter association was explained entirely by the presence of anxiety.
CONCLUSION: Anxiety symptoms were common and significantly related to ADL and additional neuropsychiatric problems in this sample. These results indicate the need for additional research into the phenomenology of anxiety and comorbid anxiety-depression in AD and for the development and investigation of effective assessment and treatment of anxiety in AD clinical practice.

Entities:  

Mesh:

Year:  1999        PMID: 10462166     DOI: 10.1093/gerona/54.7.m348

Source DB:  PubMed          Journal:  J Gerontol A Biol Sci Med Sci        ISSN: 1079-5006            Impact factor:   6.053


  56 in total

1.  Psychometric properties of a structured interview guide for the rating for anxiety in dementia.

Authors:  A Lynn Snow; Cashuna Huddleston; Christina Robinson; Mark E Kunik; Amber L Bush; Nancy Wilson; Jessica Calleo; Amber Paukert; Cynthia Kraus-Schuman; Nancy J Petersen; Melinda A Stanley
Journal:  Aging Ment Health       Date:  2012-02-28       Impact factor: 3.658

2.  Nonsteroidal selective androgen receptor modulators and selective estrogen receptor β agonists moderate cognitive deficits and amyloid-β levels in a mouse model of Alzheimer's disease.

Authors:  Sonia George; Géraldine H Petit; Gunnar K Gouras; Patrik Brundin; Roger Olsson
Journal:  ACS Chem Neurosci       Date:  2013-09-25       Impact factor: 4.418

3.  Characteristics of generalized anxiety disorder in patients with dementia.

Authors:  Jessica S Calleo; Mark E Kunik; Dana Reid; Cynthia Kraus-Schuman; Amber Paukert; Tziona Regev; Nancy Wilson; Nancy J Petersen; A Lynn Snow; Melinda Stanley
Journal:  Am J Alzheimers Dis Other Demen       Date:  2011-11-07       Impact factor: 2.035

4.  The involvement of multiple caregivers in cognitive-behavior therapy for anxiety in persons with dementia.

Authors:  Christina M Robinson; Amber Paukert; Cynthia A Kraus-Schuman; A Lynn Snow; Mark E Kunik; Nancy L Wilson; Linda Teri; Melinda A Stanley
Journal:  Aging Ment Health       Date:  2011-04       Impact factor: 3.658

5.  Individualized music for dementia: Evolution and application of evidence-based protocol.

Authors:  Linda A Gerdner
Journal:  World J Psychiatry       Date:  2012-04-22

6.  Melatonin Prevents the Harmful Effects of Obesity on the Brain, Including at the Behavioral Level.

Authors:  Adrian Rubio-González; Juan Carlos Bermejo-Millo; Beatriz de Luxán-Delgado; Yaiza Potes; Zulema Pérez-Martínez; José Antonio Boga; Ignacio Vega-Naredo; Beatriz Caballero; Juan José Solano; Ana Coto-Montes
Journal:  Mol Neurobiol       Date:  2017-10-30       Impact factor: 5.590

7.  Skin Conduction Levels Differentiate Frontotemporal Dementia From Alzheimer's Disease.

Authors:  Mario F Mendez; Sylvia S Fong; Mark M Ashla; Elvira E Jimenez; Andrew R Carr
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2018-04-06       Impact factor: 2.198

8.  Dementia-specific assisted living: clinical factors and psychotropic medication use.

Authors:  Marianne Smith; Kathleen C Buckwalter; Hyunwook Kang; Vicki Ellingrod; Susan K Schultz
Journal:  J Am Psychiatr Nurses Assoc       Date:  2008-03       Impact factor: 2.385

Review 9.  Genomic variants, genes, and pathways of Alzheimer's disease: An overview.

Authors:  Adam C Naj; Gerard D Schellenberg
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2017-01       Impact factor: 3.568

10.  The Peaceful Mind manual: a protocol for treating anxiety in persons with dementia.

Authors:  Amber L Paukert; Cynthia Kraus-Schuman; Nancy Wilson; A Lynn Snow; Jessica Calleo; Mark E Kunik; Melinda A Stanley
Journal:  Behav Modif       Date:  2013-02-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.